Second-most commonly prescribed drug for older adults is linked to bone loss
The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...
jhuapl24m
Shape-Shifting Antenna Poised to Transform Communications
Johns Hopkins APL researchers have leveraged cutting-edge additive manufacturing techniques and shape memory alloys to create ...
One major challenge facing Trump’s chosen health leaders: Keeping politics separate from science
The announcements came Friday night, one after another, President-elect Donald Trump’s picks for the country’s premier health ...
jhuapl3h
Climate Intelligence
APL is developing sensors, systems, and models to provide key intelligence on how the environment is changing and how climate ...
Medscape3h
Blood Buddies: Can Mentorship Revive Classical Hematology?
The nationwide shortage of classical hematologists is being addressed by placing greater emphasis on mentoring.
New U.S. rule will allow HIV-positive organ transplants starting Wednesday
The new rule, which takes effect Wednesday, is expected to shorten the wait for organs for all, regardless of HIV status, by ...
Baltimore City bystanders 45% less likely to perform CPR compared to state, national stats
A new study by local academics and emergency medical services found Baltimore City bystanders are less likely to provide CPR ...
Medication Prescribed to 23 Million Americans May Cause Bone Loss
Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.
ABC Action News18h
Johns Hopkins All Children's Hospital plans for $62 million expansion in 2025
In 2025, Johns Hopkins All Children’s Hospital plans to expand its space and services, including its emergency center and ...
Johns Hopkins Again Tops NSF’s List Of Schools For Most R&D Spending
Total R&D expenditures at U.S. colleges and universities topped $108.8 billion in FY 2023, an increase of $11 billion from FY ...